Rank | Gene Set | Z-score |
---|---|---|
1 | drug catabolic process (GO:0042737) | 6.92373655 |
2 | L-phenylalanine catabolic process (GO:0006559) | 6.74133773 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.74133773 |
4 | * regulation of protein activation cascade (GO:2000257) | 6.58386482 |
5 | exogenous drug catabolic process (GO:0042738) | 6.47809734 |
6 | glyoxylate metabolic process (GO:0046487) | 6.39356139 |
7 | complement activation, alternative pathway (GO:0006957) | 6.23104863 |
8 | * regulation of complement activation (GO:0030449) | 6.21768111 |
9 | regulation of fibrinolysis (GO:0051917) | 6.08464460 |
10 | L-phenylalanine metabolic process (GO:0006558) | 6.03627771 |
11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.03627771 |
12 | aromatic amino acid family catabolic process (GO:0009074) | 5.97479189 |
13 | epoxygenase P450 pathway (GO:0019373) | 5.89323695 |
14 | negative regulation of fibrinolysis (GO:0051918) | 5.70766611 |
15 | oxidative demethylation (GO:0070989) | 5.47998796 |
16 | omega-hydroxylase P450 pathway (GO:0097267) | 5.44965152 |
17 | urea metabolic process (GO:0019627) | 5.29958972 |
18 | indole-containing compound catabolic process (GO:0042436) | 5.29341781 |
19 | indolalkylamine catabolic process (GO:0046218) | 5.29341781 |
20 | tryptophan catabolic process (GO:0006569) | 5.29341781 |
21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.08571843 |
22 | protein carboxylation (GO:0018214) | 5.08571843 |
23 | cellular ketone body metabolic process (GO:0046950) | 5.01401570 |
24 | blood coagulation, intrinsic pathway (GO:0007597) | 4.84717075 |
25 | nitrogen cycle metabolic process (GO:0071941) | 4.75932946 |
26 | drug metabolic process (GO:0017144) | 4.75825459 |
27 | * negative regulation of protein activation cascade (GO:2000258) | 4.72432798 |
28 | urea cycle (GO:0000050) | 4.71837626 |
29 | regulation of triglyceride catabolic process (GO:0010896) | 4.71610677 |
30 | serine family amino acid catabolic process (GO:0009071) | 4.69958404 |
31 | bile acid biosynthetic process (GO:0006699) | 4.69530351 |
32 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.57192717 |
33 | cellular glucuronidation (GO:0052695) | 4.54557163 |
34 | aromatic amino acid family metabolic process (GO:0009072) | 4.49791980 |
35 | ketone body metabolic process (GO:1902224) | 4.44106987 |
36 | flavonoid metabolic process (GO:0009812) | 4.42668607 |
37 | tryptophan metabolic process (GO:0006568) | 4.42516649 |
38 | high-density lipoprotein particle remodeling (GO:0034375) | 4.30305708 |
39 | kynurenine metabolic process (GO:0070189) | 4.30104951 |
40 | fibrinolysis (GO:0042730) | 4.27793109 |
41 | phenylpropanoid metabolic process (GO:0009698) | 4.27568661 |
42 | uronic acid metabolic process (GO:0006063) | 4.27547748 |
43 | glucuronate metabolic process (GO:0019585) | 4.27547748 |
44 | tyrosine metabolic process (GO:0006570) | 4.27329190 |
45 | bile acid metabolic process (GO:0008206) | 4.24103300 |
46 | S-adenosylmethionine metabolic process (GO:0046500) | 4.23790134 |
47 | plasma lipoprotein particle remodeling (GO:0034369) | 4.21383468 |
48 | protein-lipid complex remodeling (GO:0034368) | 4.21383468 |
49 | macromolecular complex remodeling (GO:0034367) | 4.21383468 |
50 | indolalkylamine metabolic process (GO:0006586) | 4.18872049 |
51 | ethanol oxidation (GO:0006069) | 4.11386810 |
52 | triglyceride homeostasis (GO:0070328) | 4.10706791 |
53 | acylglycerol homeostasis (GO:0055090) | 4.10706791 |
54 | imidazole-containing compound metabolic process (GO:0052803) | 4.10672229 |
55 | * negative regulation of complement activation (GO:0045916) | 4.08357082 |
56 | negative regulation of cholesterol transport (GO:0032375) | 4.03366642 |
57 | negative regulation of sterol transport (GO:0032372) | 4.03366642 |
58 | * protein activation cascade (GO:0072376) | 4.01016074 |
59 | intestinal cholesterol absorption (GO:0030299) | 4.00361961 |
60 | glycine metabolic process (GO:0006544) | 3.99426839 |
61 | alkaloid metabolic process (GO:0009820) | 3.96976342 |
62 | reverse cholesterol transport (GO:0043691) | 3.93510150 |
63 | arginine metabolic process (GO:0006525) | 3.85699379 |
64 | bile acid and bile salt transport (GO:0015721) | 3.83691977 |
65 | alpha-amino acid catabolic process (GO:1901606) | 3.81508555 |
66 | regulation of plasminogen activation (GO:0010755) | 3.81226299 |
67 | cholesterol efflux (GO:0033344) | 3.78479626 |
68 | * regulation of humoral immune response (GO:0002920) | 3.64466012 |
69 | heme transport (GO:0015886) | 3.64014397 |
70 | acute-phase response (GO:0006953) | 3.59546866 |
71 | * complement activation, classical pathway (GO:0006958) | 3.59091073 |
72 | * complement activation (GO:0006956) | 3.56118539 |
73 | amino-acid betaine metabolic process (GO:0006577) | 3.53815450 |
74 | drug transmembrane transport (GO:0006855) | 3.50002297 |
75 | amine catabolic process (GO:0009310) | 3.46069149 |
76 | cellular biogenic amine catabolic process (GO:0042402) | 3.46069149 |
77 | cytolysis (GO:0019835) | 3.44692475 |
78 | benzene-containing compound metabolic process (GO:0042537) | 3.43233870 |
79 | negative regulation of hemostasis (GO:1900047) | 3.41441405 |
80 | negative regulation of blood coagulation (GO:0030195) | 3.41441405 |
81 | cellular amino acid catabolic process (GO:0009063) | 3.38404039 |
82 | serine family amino acid metabolic process (GO:0009069) | 3.38018248 |
83 | negative regulation of lipase activity (GO:0060192) | 3.35915352 |
84 | L-methionine salvage (GO:0071267) | 3.33874699 |
85 | L-methionine biosynthetic process (GO:0071265) | 3.33874699 |
86 | amino acid salvage (GO:0043102) | 3.33874699 |
87 | cysteine metabolic process (GO:0006534) | 3.31146783 |
88 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.28993848 |
89 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.26159967 |
90 | regulation of cholesterol esterification (GO:0010872) | 3.26030699 |
91 | ethanol metabolic process (GO:0006067) | 3.25394953 |
92 | xenobiotic catabolic process (GO:0042178) | 3.24412826 |
93 | sodium-independent organic anion transport (GO:0043252) | 3.21532770 |
94 | phospholipid efflux (GO:0033700) | 3.19640138 |
95 | plasma lipoprotein particle organization (GO:0071827) | 3.14485998 |
96 | homocysteine metabolic process (GO:0050667) | 3.10663140 |
97 | peptidyl-glutamic acid modification (GO:0018200) | 3.09253278 |
98 | negative regulation of coagulation (GO:0050819) | 3.08252767 |
99 | regulation of lipoprotein particle clearance (GO:0010984) | 3.07631465 |
100 | low-density lipoprotein particle remodeling (GO:0034374) | 3.05602725 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.57770073 |
2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.35435813 |
3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.84773225 |
4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.81935123 |
5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.80330369 |
6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.78570981 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.73272326 |
8 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.57047861 |
9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.47322460 |
10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.44528192 |
11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.40023575 |
12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.37372320 |
13 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.32347049 |
14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.28962750 |
15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.25090387 |
16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.22275729 |
17 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.97574936 |
18 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.92271884 |
19 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.90358809 |
20 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.90013220 |
21 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.88138575 |
22 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.86807113 |
23 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.75888718 |
24 | STAT3_23295773_ChIP-Seq_U87_Human | 1.75406465 |
25 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.68954035 |
26 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.68478145 |
27 | P300_19829295_ChIP-Seq_ESCs_Human | 1.67816097 |
28 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.66456572 |
29 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.66073730 |
30 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.65510266 |
31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.62972178 |
32 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.62890227 |
33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.62222771 |
34 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.59735564 |
35 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.59230364 |
36 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58061644 |
37 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.57424045 |
38 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.57130148 |
39 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.56590991 |
40 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.53875409 |
41 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.52942080 |
42 | FUS_26573619_Chip-Seq_HEK293_Human | 1.52075335 |
43 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.48800683 |
44 | TCF4_23295773_ChIP-Seq_U87_Human | 1.47472267 |
45 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.46921495 |
46 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.38970805 |
47 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.38884756 |
48 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.38884756 |
49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.37406194 |
50 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.36816615 |
51 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.36652299 |
52 | EWS_26573619_Chip-Seq_HEK293_Human | 1.32139301 |
53 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.32107533 |
54 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.28714913 |
55 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.28123742 |
56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27936079 |
57 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.27633385 |
58 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.27633385 |
59 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.25995660 |
60 | AR_20517297_ChIP-Seq_VCAP_Human | 1.23022708 |
61 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22298504 |
62 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.21031193 |
63 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.20990072 |
64 | AR_25329375_ChIP-Seq_VCAP_Human | 1.20930434 |
65 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.20665936 |
66 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.16932028 |
67 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.16722941 |
68 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.15885180 |
69 | TP53_16413492_ChIP-PET_HCT116_Human | 1.15126801 |
70 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.14653609 |
71 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.14561812 |
72 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.14373049 |
73 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.13890672 |
74 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.13745022 |
75 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.12596796 |
76 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.12483480 |
77 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.12127435 |
78 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.11836412 |
79 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.10794686 |
80 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09165897 |
81 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.09156565 |
82 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.08193230 |
83 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.08193230 |
84 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.06977929 |
85 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.05938016 |
86 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.05700531 |
87 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.05678800 |
88 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05534253 |
89 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05436663 |
90 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.04802770 |
91 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.04322352 |
92 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03516279 |
93 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.03369074 |
94 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.03219096 |
95 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.02409420 |
96 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.01619967 |
97 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.01447549 |
98 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.99934297 |
99 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99436697 |
100 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98367074 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.68677618 |
2 | MP0003195_calcinosis | 6.24632217 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.98532610 |
4 | MP0005360_urolithiasis | 5.07466241 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.99365602 |
6 | MP0005365_abnormal_bile_salt | 4.85698659 |
7 | MP0002138_abnormal_hepatobiliary_system | 3.78872650 |
8 | MP0003252_abnormal_bile_duct | 3.67672007 |
9 | MP0003868_abnormal_feces_composition | 2.93766889 |
10 | MP0010329_abnormal_lipoprotein_level | 2.88791419 |
11 | MP0002876_abnormal_thyroid_physiology | 2.77743832 |
12 | MP0001666_abnormal_nutrient_absorption | 2.72825780 |
13 | MP0009697_abnormal_copulation | 2.54295590 |
14 | MP0005332_abnormal_amino_acid | 2.36823272 |
15 | MP0001764_abnormal_homeostasis | 1.97260697 |
16 | MP0005083_abnormal_biliary_tract | 1.77506149 |
17 | MP0005551_abnormal_eye_electrophysiolog | 1.75952635 |
18 | MP0000569_abnormal_digit_pigmentation | 1.75710200 |
19 | MP0002118_abnormal_lipid_homeostasis | 1.55424385 |
20 | MP0000609_abnormal_liver_physiology | 1.50425553 |
21 | MP0008872_abnormal_physiological_respon | 1.40627123 |
22 | MP0005408_hypopigmentation | 1.30691873 |
23 | MP0003950_abnormal_plasma_membrane | 1.29556305 |
24 | MP0005670_abnormal_white_adipose | 1.28863466 |
25 | MP0003806_abnormal_nucleotide_metabolis | 1.25699380 |
26 | MP0003646_muscle_fatigue | 1.22811989 |
27 | MP0008057_abnormal_DNA_replication | 1.22683282 |
28 | MP0005645_abnormal_hypothalamus_physiol | 1.20070146 |
29 | MP0005395_other_phenotype | 1.14107794 |
30 | MP0004043_abnormal_pH_regulation | 1.13144778 |
31 | MP0001661_extended_life_span | 1.12260412 |
32 | MP0001501_abnormal_sleep_pattern | 1.10704559 |
33 | MP0004019_abnormal_vitamin_homeostasis | 1.10168749 |
34 | MP0002168_other_aberrant_phenotype | 1.07206514 |
35 | MP0005319_abnormal_enzyme/_coenzyme | 1.04343490 |
36 | MP0003718_maternal_effect | 1.04119421 |
37 | MP0005646_abnormal_pituitary_gland | 1.01890431 |
38 | MP0003879_abnormal_hair_cell | 1.01806734 |
39 | MP0009643_abnormal_urine_homeostasis | 0.96962462 |
40 | MP0005167_abnormal_blood-brain_barrier | 0.95251190 |
41 | MP0005266_abnormal_metabolism | 0.91516278 |
42 | MP0009840_abnormal_foam_cell | 0.91143717 |
43 | MP0005376_homeostasis/metabolism_phenot | 0.90611663 |
44 | MP0000598_abnormal_liver_morphology | 0.89745375 |
45 | MP0005410_abnormal_fertilization | 0.89272997 |
46 | MP0009046_muscle_twitch | 0.88109552 |
47 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.86078795 |
48 | MP0009642_abnormal_blood_homeostasis | 0.82712482 |
49 | MP0000427_abnormal_hair_cycle | 0.82515615 |
50 | MP0005636_abnormal_mineral_homeostasis | 0.79429422 |
51 | MP0005253_abnormal_eye_physiology | 0.78756010 |
52 | MP0002928_abnormal_bile_duct | 0.78294132 |
53 | MP0003656_abnormal_erythrocyte_physiolo | 0.77577222 |
54 | MP0010368_abnormal_lymphatic_system | 0.76532045 |
55 | MP0004142_abnormal_muscle_tone | 0.76261287 |
56 | MP0001986_abnormal_taste_sensitivity | 0.75470998 |
57 | MP0002078_abnormal_glucose_homeostasis | 0.75468133 |
58 | MP0002971_abnormal_brown_adipose | 0.74938327 |
59 | MP0004147_increased_porphyrin_level | 0.74438261 |
60 | MP0002938_white_spotting | 0.74371606 |
61 | MP0005220_abnormal_exocrine_pancreas | 0.72111872 |
62 | MP0005448_abnormal_energy_balance | 0.71260264 |
63 | MP0009764_decreased_sensitivity_to | 0.71104269 |
64 | MP0005187_abnormal_penis_morphology | 0.69687296 |
65 | MP0005647_abnormal_sex_gland | 0.69394251 |
66 | MP0001968_abnormal_touch/_nociception | 0.65415708 |
67 | MP0002837_dystrophic_cardiac_calcinosis | 0.65088982 |
68 | MP0009745_abnormal_behavioral_response | 0.63682803 |
69 | MP0006292_abnormal_olfactory_placode | 0.63032749 |
70 | MP0002102_abnormal_ear_morphology | 0.62926616 |
71 | MP0003953_abnormal_hormone_level | 0.62288438 |
72 | MP0010386_abnormal_urinary_bladder | 0.61910885 |
73 | MP0000371_diluted_coat_color | 0.60593075 |
74 | MP0002132_abnormal_respiratory_system | 0.60381963 |
75 | MP0008775_abnormal_heart_ventricle | 0.60364752 |
76 | MP0005334_abnormal_fat_pad | 0.58090856 |
77 | MP0001324_abnormal_eye_pigmentation | 0.56923594 |
78 | MP0000372_irregular_coat_pigmentation | 0.56042601 |
79 | MP0003122_maternal_imprinting | 0.55657995 |
80 | MP0000383_abnormal_hair_follicle | 0.54861656 |
81 | MP0003011_delayed_dark_adaptation | 0.54549768 |
82 | MP0004130_abnormal_muscle_cell | 0.54467300 |
83 | MP0003186_abnormal_redox_activity | 0.54387497 |
84 | MP0005195_abnormal_posterior_eye | 0.52910233 |
85 | MP0003638_abnormal_response/metabolism_ | 0.51530880 |
86 | MP0005084_abnormal_gallbladder_morpholo | 0.50799681 |
87 | MP0001756_abnormal_urination | 0.50365443 |
88 | MP0003698_abnormal_male_reproductive | 0.50156977 |
89 | MP0002160_abnormal_reproductive_system | 0.49444052 |
90 | MP0002736_abnormal_nociception_after | 0.49128152 |
91 | MP0002090_abnormal_vision | 0.49120223 |
92 | MP0009115_abnormal_fat_cell | 0.48921885 |
93 | MP0008058_abnormal_DNA_repair | 0.47953526 |
94 | MP0003633_abnormal_nervous_system | 0.47668071 |
95 | MP0006054_spinal_hemorrhage | 0.46991338 |
96 | MP0000013_abnormal_adipose_tissue | 0.46592863 |
97 | MP0003045_fibrosis | 0.46053107 |
98 | MP0005386_behavior/neurological_phenoty | 0.45070099 |
99 | MP0004924_abnormal_behavior | 0.45070099 |
100 | MP0002638_abnormal_pupillary_reflex | 0.44957845 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Prolonged partial thromboplastin time (HP:0003645) | 7.48129942 |
2 | Deep venous thrombosis (HP:0002625) | 7.08890820 |
3 | Hypobetalipoproteinemia (HP:0003563) | 6.69120985 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.56808324 |
5 | Complement deficiency (HP:0004431) | 6.19356379 |
6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.88472035 |
7 | Conjugated hyperbilirubinemia (HP:0002908) | 4.59072370 |
8 | Joint hemorrhage (HP:0005261) | 4.58847977 |
9 | Abnormality of complement system (HP:0005339) | 4.45708479 |
10 | Fair hair (HP:0002286) | 4.17011322 |
11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.99531755 |
12 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.96133581 |
13 | Hyperlipoproteinemia (HP:0010980) | 3.85114214 |
14 | Abnormality of the common coagulation pathway (HP:0010990) | 3.66447596 |
15 | Glomerulonephritis (HP:0000099) | 3.62024109 |
16 | Hypolipoproteinemia (HP:0010981) | 3.61059221 |
17 | Intrahepatic cholestasis (HP:0001406) | 3.58669356 |
18 | Spontaneous abortion (HP:0005268) | 3.54446632 |
19 | Xanthomatosis (HP:0000991) | 3.47880643 |
20 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.27624949 |
21 | Abnormality of alanine metabolism (HP:0010916) | 3.27624949 |
22 | Hyperalaninemia (HP:0003348) | 3.27624949 |
23 | Abnormality of the intrinsic pathway (HP:0010989) | 3.14953642 |
24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.10478792 |
25 | Systemic lupus erythematosus (HP:0002725) | 3.04033837 |
26 | Hyperventilation (HP:0002883) | 3.02966740 |
27 | Generalized hypopigmentation of hair (HP:0011358) | 3.00485940 |
28 | Hyperglycinemia (HP:0002154) | 2.95905558 |
29 | Epidermoid cyst (HP:0200040) | 2.94620728 |
30 | Cerebellar dysplasia (HP:0007033) | 2.87996116 |
31 | Abnormality of serum amino acid levels (HP:0003112) | 2.79787147 |
32 | Hyperammonemia (HP:0001987) | 2.76884513 |
33 | Ketosis (HP:0001946) | 2.76319657 |
34 | Abnormality of glycine metabolism (HP:0010895) | 2.71233782 |
35 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.71233782 |
36 | Hyperglycinuria (HP:0003108) | 2.70029892 |
37 | Alkalosis (HP:0001948) | 2.64173615 |
38 | Abnormality of the renal cortex (HP:0011035) | 2.58711390 |
39 | Bile duct proliferation (HP:0001408) | 2.58345193 |
40 | Abnormal biliary tract physiology (HP:0012439) | 2.58345193 |
41 | Generalized aminoaciduria (HP:0002909) | 2.57374135 |
42 | Retinal atrophy (HP:0001105) | 2.56714635 |
43 | Reduced antithrombin III activity (HP:0001976) | 2.56624420 |
44 | Nephritis (HP:0000123) | 2.54772219 |
45 | Ketoacidosis (HP:0001993) | 2.51514963 |
46 | Arthropathy (HP:0003040) | 2.51471378 |
47 | Vascular calcification (HP:0004934) | 2.47088500 |
48 | Abnormality of methionine metabolism (HP:0010901) | 2.46845193 |
49 | Pancreatic cysts (HP:0001737) | 2.46279918 |
50 | Renal cortical cysts (HP:0000803) | 2.42785452 |
51 | Submucous cleft hard palate (HP:0000176) | 2.42424614 |
52 | Enlarged kidneys (HP:0000105) | 2.39854001 |
53 | Chronic hepatic failure (HP:0100626) | 2.22661355 |
54 | Hypothermia (HP:0002045) | 2.19977410 |
55 | Fat malabsorption (HP:0002630) | 2.19884143 |
56 | Attenuation of retinal blood vessels (HP:0007843) | 2.19358667 |
57 | Gaze-evoked nystagmus (HP:0000640) | 2.17644206 |
58 | Hypoalphalipoproteinemia (HP:0003233) | 2.17079209 |
59 | Blue irides (HP:0000635) | 2.13512655 |
60 | Abnormality of the nasal septum (HP:0000419) | 2.13476121 |
61 | Delayed CNS myelination (HP:0002188) | 2.10791886 |
62 | Congenital stationary night blindness (HP:0007642) | 2.10401140 |
63 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.06701013 |
64 | Metabolic acidosis (HP:0001942) | 2.06313353 |
65 | Abnormality of proline metabolism (HP:0010907) | 2.05180038 |
66 | Hydroxyprolinuria (HP:0003080) | 2.05180038 |
67 | Cardiovascular calcification (HP:0011915) | 2.04906499 |
68 | Gingival bleeding (HP:0000225) | 2.03059184 |
69 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.01849963 |
70 | Menorrhagia (HP:0000132) | 2.01454641 |
71 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.98132872 |
72 | Proximal tubulopathy (HP:0000114) | 1.97610329 |
73 | True hermaphroditism (HP:0010459) | 1.96849757 |
74 | Pancreatic fibrosis (HP:0100732) | 1.96168170 |
75 | Genetic anticipation (HP:0003743) | 1.92747547 |
76 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.90728714 |
77 | Mitral stenosis (HP:0001718) | 1.89740343 |
78 | Type II lissencephaly (HP:0007260) | 1.88094022 |
79 | Lethargy (HP:0001254) | 1.88058625 |
80 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.87774166 |
81 | Hypercholesterolemia (HP:0003124) | 1.87366237 |
82 | Abnormality of nucleobase metabolism (HP:0010932) | 1.85591703 |
83 | Cerebral edema (HP:0002181) | 1.82829250 |
84 | Facial shape deformation (HP:0011334) | 1.82648621 |
85 | Potter facies (HP:0002009) | 1.82648621 |
86 | Hepatocellular carcinoma (HP:0001402) | 1.77882943 |
87 | Abolished electroretinogram (ERG) (HP:0000550) | 1.76725337 |
88 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.75492039 |
89 | Decreased central vision (HP:0007663) | 1.71953718 |
90 | Molar tooth sign on MRI (HP:0002419) | 1.71057219 |
91 | Abnormality of midbrain morphology (HP:0002418) | 1.71057219 |
92 | Glycosuria (HP:0003076) | 1.68860310 |
93 | Abnormality of urine glucose concentration (HP:0011016) | 1.68860310 |
94 | Opisthotonus (HP:0002179) | 1.68439420 |
95 | Osteomalacia (HP:0002749) | 1.68215848 |
96 | Increased corneal curvature (HP:0100692) | 1.66185681 |
97 | Keratoconus (HP:0000563) | 1.66185681 |
98 | Inability to walk (HP:0002540) | 1.65646525 |
99 | Tubular atrophy (HP:0000092) | 1.64082891 |
100 | Cystic liver disease (HP:0006706) | 1.61822542 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FRK | 8.48694769 |
2 | PDK2 | 4.54923711 |
3 | ACVR1B | 3.42492624 |
4 | WNK4 | 2.96491242 |
5 | BMPR1B | 2.79337371 |
6 | STK39 | 2.43564103 |
7 | ADRBK2 | 2.36373800 |
8 | INSRR | 2.33803309 |
9 | MAP4K2 | 2.20828218 |
10 | ZAK | 2.08364044 |
11 | OXSR1 | 2.05422206 |
12 | AKT3 | 1.93950789 |
13 | PIK3CG | 1.81947358 |
14 | WNK3 | 1.63253034 |
15 | TAOK3 | 1.62933699 |
16 | STK38L | 1.44373576 |
17 | MST1R | 1.43148922 |
18 | GRK1 | 1.43048299 |
19 | BRSK2 | 1.32256101 |
20 | NUAK1 | 1.27237605 |
21 | TLK1 | 1.21278836 |
22 | PRKAA2 | 1.21176301 |
23 | MAPK13 | 1.17746464 |
24 | LATS1 | 1.17695910 |
25 | CAMKK2 | 1.13781327 |
26 | PINK1 | 1.12902276 |
27 | PIK3CA | 1.12327360 |
28 | CASK | 1.04571759 |
29 | FER | 1.03092171 |
30 | PBK | 1.01374783 |
31 | ADRBK1 | 0.95547657 |
32 | MAPKAPK3 | 0.94952587 |
33 | MAP3K4 | 0.91876766 |
34 | PRKCG | 0.90377009 |
35 | NTRK3 | 0.89925743 |
36 | FGFR3 | 0.89884624 |
37 | MAPK11 | 0.88920598 |
38 | MAP2K6 | 0.82377370 |
39 | PRKCE | 0.79539633 |
40 | MKNK2 | 0.78199002 |
41 | MET | 0.76977723 |
42 | NEK6 | 0.76544807 |
43 | EIF2AK3 | 0.75438151 |
44 | PRKAA1 | 0.70285284 |
45 | NEK1 | 0.70164634 |
46 | NLK | 0.70028097 |
47 | TXK | 0.61024311 |
48 | STK3 | 0.60043122 |
49 | MAP3K7 | 0.59541261 |
50 | PRKACG | 0.59502987 |
51 | EPHA3 | 0.57535207 |
52 | CSNK1G1 | 0.56203124 |
53 | PAK3 | 0.55674991 |
54 | MAPKAPK5 | 0.55509347 |
55 | ERBB3 | 0.54259361 |
56 | FGFR2 | 0.53740906 |
57 | BCKDK | 0.52480016 |
58 | DAPK2 | 0.52227720 |
59 | IRAK1 | 0.52041636 |
60 | BCR | 0.51153537 |
61 | PRKACA | 0.50950853 |
62 | ERBB2 | 0.49982734 |
63 | CSNK1A1L | 0.49928327 |
64 | CSNK1D | 0.49267769 |
65 | PDK1 | 0.46713931 |
66 | PRKACB | 0.45433943 |
67 | MUSK | 0.43037034 |
68 | TEC | 0.43034031 |
69 | SIK2 | 0.42922175 |
70 | MKNK1 | 0.41649097 |
71 | TGFBR1 | 0.40883380 |
72 | MARK1 | 0.40648447 |
73 | FGFR4 | 0.40377668 |
74 | STK38 | 0.39882621 |
75 | IGF1R | 0.39736223 |
76 | MAP2K1 | 0.39632165 |
77 | NEK2 | 0.38954572 |
78 | SGK2 | 0.36450698 |
79 | PRKCA | 0.35549721 |
80 | TNK2 | 0.35367052 |
81 | CAMK1G | 0.34584562 |
82 | STK11 | 0.34292679 |
83 | FLT3 | 0.34096100 |
84 | SGK1 | 0.33869028 |
85 | IKBKB | 0.33794462 |
86 | CAMK1D | 0.33207725 |
87 | BRD4 | 0.33127231 |
88 | PRKG1 | 0.32631715 |
89 | TRIM28 | 0.32127315 |
90 | PDPK1 | 0.31703594 |
91 | OBSCN | 0.31600039 |
92 | EPHA4 | 0.31349649 |
93 | NME1 | 0.30864244 |
94 | MELK | 0.30753469 |
95 | ATR | 0.30221169 |
96 | CSNK1E | 0.30191940 |
97 | CHUK | 0.30031867 |
98 | CAMK2A | 0.30013001 |
99 | PRKCB | 0.29807069 |
100 | MAP2K7 | 0.29704124 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.67828820 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.60717927 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.20479202 |
4 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.14639578 |
5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.12534078 |
6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.11792588 |
7 | Retinol metabolism_Homo sapiens_hsa00830 | 2.93929927 |
8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.67577333 |
9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.64585296 |
10 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.63978689 |
11 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.62436001 |
12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.53127138 |
13 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.48115948 |
14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.30365549 |
15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.25621366 |
16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.24754908 |
17 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.12209497 |
18 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.04633877 |
19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.99217061 |
20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.98745010 |
21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.91347066 |
22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.87537738 |
23 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.86163249 |
24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.79816518 |
25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.77190938 |
26 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.71521014 |
27 | ABC transporters_Homo sapiens_hsa02010 | 1.64771118 |
28 | Bile secretion_Homo sapiens_hsa04976 | 1.57374203 |
29 | Peroxisome_Homo sapiens_hsa04146 | 1.52319451 |
30 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.48384704 |
31 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.44037471 |
32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.42312491 |
33 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.41939924 |
34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.33050496 |
35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30119904 |
36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.29205183 |
37 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.29107830 |
38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27876657 |
39 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.19573477 |
40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14061239 |
41 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.12074684 |
42 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.09799893 |
43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.07552294 |
44 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.04195236 |
45 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.02287104 |
46 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.95237170 |
47 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.94831730 |
48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90943000 |
49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.90136863 |
50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.88899707 |
51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.88318129 |
52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.78812987 |
53 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.78613791 |
54 | Lysine degradation_Homo sapiens_hsa00310 | 0.75819197 |
55 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.73426870 |
56 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69461752 |
57 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.68211068 |
58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59812753 |
59 | Metabolic pathways_Homo sapiens_hsa01100 | 0.58832956 |
60 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.54945473 |
61 | Sulfur relay system_Homo sapiens_hsa04122 | 0.54777889 |
62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.50404890 |
63 | Phototransduction_Homo sapiens_hsa04744 | 0.50035042 |
64 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.45252382 |
65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.42371694 |
66 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.40848449 |
67 | Carbon metabolism_Homo sapiens_hsa01200 | 0.40778440 |
68 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.38327597 |
69 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.37417571 |
70 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35223515 |
71 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33105187 |
72 | Homologous recombination_Homo sapiens_hsa03440 | 0.28904005 |
73 | Circadian rhythm_Homo sapiens_hsa04710 | 0.27725320 |
74 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.27550209 |
75 | Mineral absorption_Homo sapiens_hsa04978 | 0.27494628 |
76 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.27368411 |
77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.23019896 |
78 | Insulin resistance_Homo sapiens_hsa04931 | 0.22936097 |
79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22660414 |
80 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.22414172 |
81 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.21950641 |
82 | Nicotine addiction_Homo sapiens_hsa05033 | 0.18644319 |
83 | Prion diseases_Homo sapiens_hsa05020 | 0.18539801 |
84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.15883581 |
85 | Taste transduction_Homo sapiens_hsa04742 | 0.15612896 |
86 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.13755545 |
87 | Morphine addiction_Homo sapiens_hsa05032 | 0.12768138 |
88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.11298382 |
89 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.10034337 |
90 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.09934493 |
91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.09412360 |
92 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.09205360 |
93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.07995868 |
94 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.07111443 |
95 | GABAergic synapse_Homo sapiens_hsa04727 | 0.06264424 |
96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.06043508 |
97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.05618582 |
98 | Purine metabolism_Homo sapiens_hsa00230 | 0.03970835 |
99 | Olfactory transduction_Homo sapiens_hsa04740 | 0.03491390 |
100 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.02616177 |